BioAgilytix Labs

MicroConstants is a bioanalytical testing services provider with over 20 years of experience, primarily serving clients in the pharmaceutical and biotech sectors. Established in 2007 by Dr. Lin Nianjia, the company specializes in Good Laboratory Practice (GLP) compliant bioanalytical services, offering expertise in pharmacokinetics and early clinical trials for both new and generic drugs. Located in San Diego, California, MicroConstants operates a modern facility equipped with advanced technology, including numerous LC/MS/MS systems. The company has successfully conducted bioanalytical testing for a wide range of macromolecules, peptides, and small molecule drugs, catering to over 500 international pharmaceutical clients. Its commitment to quality is demonstrated by successfully passing multiple inspections by regulatory agencies, including the FDA.

360biolabs is a leading specialty laboratory services organization in Australia, focused on providing comprehensive support for the development of therapeutics, vaccines, and diagnostics. The company specializes in developing and conducting pharmacokinetic (PK) and pharmacodynamic (PD) assays across various therapeutic areas. By offering extensive laboratory services and specialist expertise, 360biolabs aids clients in navigating the complexities of preclinical studies and clinical trials. Their commitment to delivering accurate, reproducible, and robust assay data enables clients to advance therapeutic candidates effectively through regulatory review processes.

Cambridge Biomedical Inc. is a contract research organization and diagnostic laboratory based in Boston, Massachusetts, specializing in bioanalytical services for life science companies. Established in 1997, the company offers an array of custom assay solutions, including assay development, validation, optimization, and biomarker assays, as well as regulatory consulting and quality assurance services. Cambridge Biomedical also provides comprehensive clinical diagnostics, featuring cell-based assays, immunogenicity studies, and quantitative immunoassays. Its expertise supports the entire drug development process, from preclinical stages through phase IV clinical trials and post-market testing. The company serves a diverse clientele, including contract research organizations, medical device developers, biotech and pharmaceutical companies, and reference laboratories. As of November 2019, Cambridge Biomedical operates as a subsidiary of BioAgilytix Labs, LLC.

IPM BIOTECH is a biotechnology company based in Hamburg, Germany. It specializes in providing laboratory services, with a focus on bioanalytical contract research for immune-mediated diseases and disorders. The company is dedicated to advancing the understanding and treatment of these conditions through its innovative research and development efforts.